INTRODUCTION
============

Multidetector computed tomography (MDCT) is one of the most commonly used medical imaging modalities. Fast image acquisition and high spatial resolutions has made computed tomography (CT) a workhorse of diagnostic medical imaging. Meanwhile, there is inevitable radiation exposure from CT examination. The widening of clinical applications and utility of CT has resulted in complex multiphase scanning and increased scan ranges that exacerbate the CT radiation problem. Benner and Hall reported with small but significant risk from radiation doses of routine CT examinations in 2007 ([@B1]). Another report in 2009 estimated about 29,000 future cancers could be related to CT scans performed in the US in 2007, which is equivalent to approximated 2% of annual US cancer ([@B2]). Currently, emerging concerns regarding the hazard from medical radiation including CT examinations has been suggested ([@B1][@B3][@B4][@B5][@B6]).

There were many reports about the CT techniques and image-processing algorisms for reduced radiation doses ([@B7][@B8][@B9][@B10]). In spite of these promising researches, all CT machines used in present daily practices are not compatible with these latest scanning or post-scanning processes. Furthermore, these new methods and imaging processing require further validation in various clinical settings. In the meantime, practical strategies for reduction of radiation exposure from CT scans in daily practice are needed. These include the modification of imaging acquisition protocols and replacement of CT examinations with other ionizing radiation-free examinations. In this step, the role of radiologists is important, as a supervisor of imaging quality control and guidance for selection of proper imaging tools. Their efforts could be observed on longitudinal changes of radiation doses from CT scan. To observe variation of this change according to different CT examinations and different institutions' clinical settings, multicenter study is desirable. The aim of this study is to observe the longitudinal changes of CT radiation doses of various CT protocols and to estimate the long-term efforts of supervising radiologists to optimize CT protocols and reduce medical radiation.

MATERIALS AND METHODS
=====================

Study subjects and CT protocol selection
----------------------------------------

Twelve tertiary and secondary hospitals participated in this study. These hospitals are equipped with more than one MDCT. In consensus meeting of 12 radiologists of participating hospitals, they chose CT protocols to be included in this study. They were all board-certificate radiologists and had experiences more than 10 years for sub-special radiology division. After selection of three body parts, abdomen, chest and brain, nine representative CT protocols of three body parts were chosen. These were the major CT examinations of daily practices: dynamic-contrast-enhanced CT of the liver (CT~liver~), routine abdomen CT (CT~abdomen~), non-enhanced CT for urolithiasis (CT~stone~), routine chest CT (CT~chest~), high resolution chest CT (HRCT), low dose chest CT (LDCT), non-enhanced brain CT (CT~brain~), and CT angiography of the brain (CTA~brain~). In addition, three CT protocols with high impact on radiation exposure had included; CT urography (CTU), coronary CT angiography (CTA~coronary~) and CT perfusion study of the brain (CTP~brain~). As a result, 11 CT protocols of three body parts were chosen to be assessed in this study.

Data collection
---------------

For each protocols, two sets of CT dose data were collected; first in March 2007, just after the widespread adaptation of MDCT in participating hospitals, and before publication of a pivotal paper by Brenner and Hall ([@B1]), and second in March 2010, after 3-year clinical experiences with the installed MDCTs. Using a radiology database, 10 CT examinations were randomly selected per CT protocol and CT machine in each time, and their CT protocol and radiation dose data were collected. Because the different body habitus and different CT protocols, pediatric patients younger than 17-year-old were excluded. Image quality of the included CT scans was evaluated by each hospital radiologist, and if the image quality was suboptimal, that CT examination was excluded. If there were less than 10 CT examinations during 10 days, all of them were collected. Collected data included patient age, sex, the volume CT dose index (CTDI~vol~) of each phase, number of phases, dose length product (DLP) of each phase, and used CT machines. After calculation of total DLP of each CT examinations, effective doses (ED) were calculated from total DLP with coefficient factors ([@B11][@B12]). CT machines were divided into 3 types according to the technical features; CT with less than 64 detector rows (type A CT), CT with 64 or more detector rows (type B CT) and dual source CT (type C CT). To differentiate the effect of the protocol changes and that of CT machine changes, a subgroup was defined: If the same CT machines were used both in 2007 and 2010 for same protocols in same hospitals, the dose data from these CTs were defined as group 1.

Statistical analysis
--------------------

After assessment of descriptive statistics of CT dose data in 2007 and 2010, three radiation measurements, mean values of CTDI~vol~, total DLP and ED, were compared according to protocols. This comparison was done in total data and group 1 data. In addition, comparison of radiation exposures according to CT machines was made. For group 1 data, we analyzed the changes of CT radiations of individual hospitals, to observe the effect various clinical settings to radiation dose reduction. Null hypotheses of no difference were rejected if *P* values were less than 0.05. All analyses were performed with R (version 3.2.2, R Foundation, Vienna, Austria; <https://www.R-project.org>) statistical packages.

Ethics statement
----------------

This retrospective study was approved by the institutional review board of Seoul St. Mary's Hospital (IRB No. XC10EIMI0004K) and institutional review boards of other participating hospitals. Informed consent was waived by the board.

RESULTS
=======

CT dose and hardware data collection
------------------------------------

Four hospitals did not have the CT dose report of individual patients at 2007 and their data could not be collected. As a result, CT radiation dose data of 2007 was collected from 20 CT machines of 8 hospitals. For 2010, data from 32 CT machines of 12 hospitals were collected ([Table 1](#T1){ref-type="table"}). 12 CT machines had been newly introduced after March 2007. In summary, 14 CT machines were used both in 2007 and 2010 for same protocols in same hospitals, and the dose data from these CTs were defined as group 1. CT machines were constituted with 14 models of four venders. The numbers of CT machines were summarized in [Table 1](#T1){ref-type="table"}. A total 1,101 CT dose data of 2007 (586 men and 515 women) and 2,391 CT dose data of 2010 (1,248 men and 1,143 women) were collected. Mean age of 2007 was 56.22 years and 2010 was 54.77 (*P* = 0.012). Among them, 996 data of 2007 (533 men and 463 women) and 1,008 data of 2010 (531 men and 477 women) were included in group 1 (mean age 56.34 in 2007 and 54.0 year old in 2010, *P* = 0.001). All dual source CTs were introduced after 2007, so there was no Type C CT in the group 1.

###### Hardware specification of studied CT scanners

![](jkms-31-S24-i001)

  Machine type                  2007   2010   Group 1
  ----------------------------- ------ ------ ---------
  Detector row \< 64 (type A)   11     13     7
  Detector row ≥ 64 (type B)    9      15     7
  Dual source (type C)          0      4      0
   Total number                 20     32     14

CT dose changes according to protocols
--------------------------------------

Mean ED of 10 CT protocols had decreased during the 3 years both in total data and group 1 ([Table 2](#T2){ref-type="table"}). Except for CTA~brain~ in group 1, the decrement was statistically significant ([Table 2](#T2){ref-type="table"}). In the total data ([Fig. 1A](#F1){ref-type="fig"}), CT~abdomen~ CTU, HRCT, and CTA~coronary~ showed almost more than 30% decrement of ED. This tendency was observed similarly in group 1 data ([Fig. 1B](#F1){ref-type="fig"}), except for CTA~brain~. CDTI~vol~; and total DLP ([Table 3](#T3){ref-type="table"}) were also decreased in 10 protocols in 2010 as compared with 2007 in all patients ([Fig. 2A](#F2){ref-type="fig"}) and group 1 ([Fig. 2B](#F2){ref-type="fig"}). CTDI~vol~ of CT~liver~ did not show significant change. All protocols showed more than 10% decrement of mean total DLP during the three years ([Fig. 2A](#F2){ref-type="fig"}). Among them, CT~abdomen~, HRCT, and CTA~coronary~ showed more than 40% decrement of total DLP. In group 1 ([Fig. 2B](#F2){ref-type="fig"}), all protocols except for CT~brain~ showed more than 10% decrement of CDTI~vol~ and total DLP. CT~abdomen~, CTU, CT~stone~, HRCT, LDCT, CTA~coronary~ and CTP~brain~ showed 20% or more decrement of total DLP in group 1. CT~liver~, CT~abdomen~, and HRCT showed more decreased total DLP than CDTI~vol~. On the contrary, three head CT protocols (CT~brain~, CTA~brain~, and CTP~brain~) showed larger decrement of CTDI~vol~ than total DLP.

###### Comparison of effective doses between 2007 and 2010: total data and group 1 data
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  Protocols        Total   Group 1                                                                                  
  ---------------- ------- --------- ------------- ------------ ---------- ------ ------ ------------- ------------ ----------
  yr               2007    2010      2007          2010                    2007   2010   2007          2010         
   CT~liver~       130     289       22.8 ± 9.1    19.9 ± 8.0   0.002      120    119    22.8 ± 9.1    19.7 ± 7.4   0.001
   CT~abdomen~     139     299       16.7 ± 8.2    9.8 ± 6.1    \< 0.001   129    126    16.7 ± 8.2    10.1 ± 7.1   \< 0.001
   CTU             58      196       30.3 ± 11     20.9 ± 8.7   \< 0.001   48     50     30.3 ± 11.0   19.1 ± 9.5   \< 0.001
   CT~stone~       119     270       8.8 ± 3.2     6.7 ± 3.4    \< 0.001   116    120    8.8 ± 3.2     6.7 ± 3.9    \< 0.001
   CT~chest~       140     283       8.8 ± 3.6     7.2 ± 3.2    \< 0.001   130    129    8.8 ± 3.6     7.3 ± 3.1    \< 0.001
   HRCT            90      181       12.0 ± 11.7   4.9 ± 3.1    \< 0.001   80     80     12.0 ± 11.7   5.9 ± 3.4    \< 0.001
   LDCT            110     226       1.8 ± 1.6     1.1 ± 0.5    \< 0.001   100    100    1.8 ± 1.6     1.2 ± 0.4    \< 0.001
   CTA~coronary~   60      110       17.2 ± 7.7    10.9 ± 6.1   \< 0.001   40     40     17.2 ± 7.7    9.8 ± 6.6    \< 0.001
   CT~brain~       115     237       2.2 ± 0.8     1.8 ± 0.6    \< 0.001   105    106    2.2 ± 0.8     2.0 ± 0.4    0.027
   CTA~brain~      80      180       4.3 ± 2.5     3.6 ± 1.7    0.028      70     68     4.3 ± 2.5     4.1 ± 1.6    0.499
   CTP~brain~      60      120       8.5 ± 5.5     6.0 ± 3      0.001      58     70     8.5 ± 5.5     6.4 ± 2.8    0.006
  Total            1101    2391                                            996    1008                              

CT~liver~, dynamic-contrast-enhanced CT of the liver; CT~abdomen~, routine abdomen CT; CTU, CT urography; CT~stone~, non-enhanced CT for urolithiasis; CT~chest~, routine chest CT; HRCT, high resolution chest CT; LDCT, low dose chest CT; CTA~coronary~, coronary CT angiography; CT~brain~, non-enhanced brain CT; CTA~brain~, CT angiography of the brain: CTP~brain~, CT perfusion study of the brain.

![Mean effective doses according to 11 CT protocols. (**A**) Total data comparison between 2007 and 2010. (**B**) Comparison from the data of same CT scanners from 2007 and 2010 (group 1).](jkms-31-S24-g001){#F1}

###### Comparison of CTDIvol and total DLP between 2007 and 2010
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  Protocols       Total           Group 1                                                                                                                                                 
  --------------- --------------- --------------- ---------- ----------------- ----------------- ---------- --------------- --------------- ---------- ----------------- ---------------- ----------
                  2007            2010                       2007              2010                         2007            2010                       2007              2010             
  CT~liver~       11.5 ± 4.2      11.2 ± 4.3      0.459      1511.5 ± 607.9    1288.3 ± 485.6    \< 0.001   11.5 ± 4.2      10.1 ± 3.8      0.002      1511.5 ± 607.9    1298.9 ± 490.6   0.001
  CT~abdomen~     11.2 ± 3.6      9.9 ± 3.3       \< 0.001   1101.4 ± 531.8    649.1 ± 403.1     \< 0.001   11.2 ± 3.6      9.3 ± 2.8       \< 0.001   1101.4 ± 531.8    670.9 ± 469.1    \< 0.001
  CTU             12.5 ± 3.8      9.2 ± 3.5       \< 0.001   2008.7 ± 730.4    1389.1 ± 579.1    \< 0.001   12.5 ± 3.8      8.2 ± 3.5       \< 0.001   2008.7 ± 730.4    1263.8 ± 632.7   \< 0.001
  CT~stone~       11.2 ± 3.7      8.7 ± 4.2       \< 0.001   583.4 ± 211.0     446.7 ± 226.7     \< 0.001   11.2 ± 3.7      8.2 ± 4.6       \< 0.001   583.4 ± 211.0     444.5 ± 257.8    \< 0.001
  CT~chest~       10.9 ± 3.2      8.3 ± 3.6       \< 0.001   625.9 ± 252.0     511.4 ± 225.2     \< 0.001   10.9 ± 3.2      8.3 ± 2.8       \< 0.001   625.9 ± 252.0     520.1 ± 219.3    \< 0.001
  HRCT            14.4 ± 10.9     7.9 ± 2.7       \< 0.001   854.3 ± 838.2     349.6 ± 218.6     \< 0.001   14.4 ± 10.9     8.6 ± 2.6       \< 0.001   854.3 ± 838.2     420.3 ± 245.8    \< 0.001
  LDCT            3.3 ± 3.0       2.1 ± 0.8       \< 0.001   124.8 ± 112.0     78.5 ± 32.1       \< 0.001   3.3 ± 3.0       2.3 ± 0.8       \< 0.001   124.8 ± 112.0     85.0 ± 31.8      \< 0.001
  CTA~coronary~   62.1 ± 25.7     38.4 ± 22.4     \< 0.001   1181.4 ± 527.1    675.7 ± 375.9     \< 0.001   62.1 ± 25.7     36.3 ± 23.5     \< 0.001   1181.4 ± 527.1    650.3 ± 391.3    \< 0.001
  CT~brain~       64.7 ± 21.0     49.5 ± 12.2     \< 0.001   1053.0 ± 397.4    853.5 ± 267.0     \< 0.001   64.7 ± 21.0     54.6 ± 8.8      \< 0.001   1053.0 ± 397.4    963.0 ± 211.4    0.027
  CTA~brain~      41.5 ± 14.0     33.0 ± 12.3     \< 0.001   2006.0 ± 1182.1   1703.1 ± 790.9    0.029      41.5 ± 14.01    35.4 ± 11.0     \< 0.001   2006.0 ± 1182.1   1909.6 ± 752.8   0.489
  CTP~brain~      667.2 ± 359.9   396.8 ± 215.6   \< 0.001   4043.8 ± 2620.9   2836.0 ± 1427.7   0.001      667.2 ± 359.9   418.4 ± 212.3   \< 0.001   4043.8 ± 2620.9   3036.1±1319.4    0.007

CT~liver~, dynamic-contrast-enhanced CT of the liver; CT~abdomen~, routine abdomen CT; CTU, CT urography; CT~stone~, non-enhanced CT for urolithiasis; CT~chest~, routine chest CT; HRCT, high resolution chest CT; LDCT, low dose chest CT; CTA~coronary~, coronary CT angiography; CT~brain~, non-enhanced brain CT; CTA~brain~, CT angiography of the brain: CTP~brain~, CT perfusion study of the brain.

![Percentage changes of the volume CT dose index (CTDI~vol~) and total dose-length product (DLP) of 11 CT protocols. (**A**) Total data comparison between 2007 and 2010. (**B**) Comparison from data of same CT scanners from 2007 and 2010 (group 1). Note the discrepancies between reduction of CTDI~vol~ and total DLP in CT~liver~, CT~abdomen~, and HRCT. A similar trend was observed in group 1.](jkms-31-S24-g002){#F2}

CT radiation dose changes according to machines
-----------------------------------------------

Type A CT showed generally smaller decrement of mean ED of each protocol than those of type B CT ([Table 4](#T4){ref-type="table"}). Only the CT~abdomen~ showed statistically significant decrement (*P* \< 0.001). CTA~brain~ showed significantly increased ED during 3 years. On the other hand, ED of type B CT had showed significantly decreased ED during 3 years, including CTA~brain~.

###### Comparison of effective doses between 2007 and 2010: type A and B CTs
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  Protocols        Type A CT   Type B CT                                                                                 
  ---------------- ----------- ----------- ------------- ------------ --------- ------ ------ ------------- ------------ ---------
  yr               2007        2010        2007          2010                   2007   2010   2007          2010         
   CT~liver~       60          60          2.0 ± 6.7     17.8 ± 6.4   0.047     60     59     26.1 ± 10.5   21.2 ± 8.4   0.003
   CT~abdomen~     60          58          14.8 ± 5.5    9.3 ± 4.0    \<0.001   69     68     18.7 ± 9.9    10.6 ± 8.6   \<0.001
   CTU             19          20          24.4 ± 10.9   21.6 ± 8.1   0.340     29     30     33.2 ± 9.9    17.9 ± 9.4   \<0.001
   CT~stone~       46          50          7.3 ± 2.6     7.1 ± 2.7    0.680     70     70     9.8 ± 3.2     6.4 ± 4.6    \<0.001
   CT~chest~       60          60          7.9 ± 2.4     7.8 ± 2.4    0.775     70     69     9.7 ± 4.3     7.2 ± 3.6    \<0.001
   HRCT            40          40          5.4 ± 3.2     5.1 ± 3.4    0.671     40     40     17.2 ± 13.4   6.8 ± 3.5    \<0.001
   LDCT            50          50          1.3 ± 0.5     1.3 ± 0.5    0.972     50     50     2.1 ± 2.1     1.1 ± 0.4    \<0.001
   CTA~coronary~   0           0                                                40     40     17.2 ± 7.7    11.3 ± 6.7   \<0.001
   CT~brain~       56          57          2.0 ± 0.4     2.0 ± 0.5    0.608     49     49     2.6 ± 1.1     2.1 ± 0.5    0.003
   CTA~brain~      20          19          2.3 ± 2.0     4.2 ± 2.2    0.001     50     49     5.3 ± 2.1     4.1 ± 1.4    \<0.001
   CTP~brain~      20          20          4.7 ± 1.7     3.8 ± 1.8    0.113     38     50     10.7 ± 5.7    7.3 ± 2.6    \<0.001
  Total            431         434                                              565    574                               

CT~liver~, dynamic-contrast-enhanced CT of the liver; CT~abdomen~, routine abdomen CT; CTU, CT urography; CT~stone~, non-enhanced CT for urolithiasis; CT~chest~, routine chest CT; HRCT, high resolution chest CT; LDCT, low dose chest CT; CTA~coronary~, coronary CT angiography; CT~brain~, non-enhanced brain CT; CTA~brain~, CT angiography of the brain: CTP~brain~, CT perfusion study of the brain.

CT radiation dose changes of each hospital
------------------------------------------

[Fig. 3](#F3){ref-type="fig"} showed the 3-year changes of mean EDs of 8 hospitals in group 1. There was general tendency of decrement of mean EDs during three years. However, the level of changes were various according to hospital and protocols. Hospital 7 showed profound decrement of mean EDs in almost all protocols. Hospital 3 showed little change of mean EDs during the 3 years ([Fig. 3](#F3){ref-type="fig"}). Hospital 4 showed overt decrement of mean ED in chest CT examinations, while other CT protocols showed little change. Other hospitals showed mixed nature of changes.

![Changes of mean effective doses of 8 hospitals in group 1. Note the variability of EDs at 2007 and changes during 3 years according to the protocols.](jkms-31-S24-g003){#F3}

DISCUSSION
==========

In this study, we observed radiation exposures from CT in 2007 and 2010, and found significant reduction of radiation exposures from various CT protocols in three major body parts during 3 years. These reductions were acquired while maintaining image quality that was suitable for clinical practice. There are several published guidelines and recommendations for CT examinations, which includes indications of CT examinations, recommended standard scanning protocols, and diagnostic reference levels ([@B4][@B5][@B13][@B14][@B15][@B16][@B17][@B18]). In addition to these guidelines and recommendation, there are well-known variable ways to reduce radiation from CT scans, including usage of an automated exposure control system and modification of acquisition parameters such as peak voltage (kVp), mAs, pitch, section thickness and number of phases ([@B3][@B5][@B16][@B19][@B20][@B21]). Radiologists should be familiar with these strategies, and apply these in clinical settings. Recently, there were several reports which showed the value of CT dose reduction which were led by radiology departments ([@B19][@B22]). Another research suggested the value of the effect of education of a one-day workshop for the radiologists and technicians ([@B23]). However, previous studies observing the CT radiation exposure were cross sectional studies and short term follow up studies ([@B4][@B14][@B22][@B23]). On the other hand, this multi-center study focused on the longitudinal changes of radiation doses from variable CT protocols. With three-year interval of this study, we could assess the cumulative efforts of radiologists and physicians for the reduction of medical radiation from CT examinations during three years.

Among three major CT dose parameters, CTDI~vol~ were decreased almost all protocols, which means a general tendency toward optimization of scanning parameters such as kVP, mAs, and pitch. Although decrement of total DLP had a similar trend with that of CTDI~vol~ in general, there were variable discrepancies between decrement of CTDI~vol~ and total DLP. For example, CT~abdomen~ showed more decrement of total DLP than CTDI~vol~. It suggested the optimization of scanning ranges and phase numbers as well as acquisition parameters to reduce radiation exposures. On the other hand, brain CT protocols showed less decrement of total DLP than those of CTDI~vol~, which means, widened coverage and/or additional scanning phases. This result suggested variability of CT protocol optimization according to clinical demands. Three CT protocols (CTU, CTP~brain~ and CTA~coronary~) were included this study, because it had relatively high radiation exposure. Changes of these protocols showed significant reduction of CTDI~vol~, total DLP and ED. Because, those protocols were relatively new clinical application of CT, optimizing the radiation doses of them were important. Our result showed significant reduction of radiation exposures of those protocols, suggesting collective efforts and concerns of medical society.

CT radiation dose reduction was observed prominently in newer CT scanner (type B CT, MDCT ≥ 64 channel). After 3-year clinical experiences, CT protocols performed in those newer CT scanner had been tailored according to radiation dose, while maintaining image quality. On the other hand, type A CTs showed modest decrement during three years, except for routine abdomen protocols. Type A CTs generally were introduced earlier than type B CTs, which meant more clinical experiences with type A CTs than type B CTs. Difference of clinical experience between the type A and B CTs could result difference of degree of CT dose optimization in 2007, and there could be smaller room for optimization during 3 years. It should be addressed that type A routine abdomen CT showed significant decrement of mean ED. This suggests that sustained efforts to reduce of radiation exposures and careful CT protocol optimization could be effective without newer machines or software. This finding was concordant with the previous report that optimization of CT protocols required comprehensive approach and sustainable feedback ([@B22]).

Whereas a general tendency of radiation dose decrement was observed, the change of CT radiation exposures in each hospital was heterogeneous. Especially, the changes of mean ED during three years were quite different between hospital 3 and 7. There were substantial decrement of hospital 7 whereas little change of hospital 3 during 3 years. This finding suggested the importance of a hospital's clinical setting and attending radiologists as a factor of CT radiation exposures. Different clinical settings and clinical demands of variable hospitals could result different protocol optimization of each protocol. However, more efforts to decrease the inter-hospital variability of radiation exposure from CT scans, standard scanning protocols and recommendations are needed.

Issues about medical radiation hazard are not a simple problem of radiation exposure. ALARA principle is a basic strategy for medical radiation optimization ([@B20][@B21]). There is some trade-off between image quality and radiation dose, and the balance between the acceptable image quality and lowest level of radiation exposure is a goal of CT protocol optimization ([@B8][@B19][@B21][@B22]). Under the ALARA principle, the target level of CT dose reduction is 'as reasonably as achievable.' It could be an ambiguous standard, but a sensible approach for complicated decision making. To achieve this goal, the role of radiologists to supervise CT protocols and image quality is important. Radiologists who have interest in about the medical radiation hazard, especially CT which are responsible for majority of medical radiation, should monitor radiation exposure from CT and manage appropriately with the ALARA principle. On the other hand, some radiologists may put more importance on the image quality and amount of information rather than cutting radiation off. This luxury could result in sub-optimization of CT scans regarding the point of justification of medical radiation. It could be another source of variations between hospitals, and educational programs regarding the CT radiation exposures and reduction strategies are needed. In addition, four hospitals did not collect the patient radiation dose data in 2007, and all of them had dose data in 2010. Individual record of medical radiation exposure is another important topic for managing medical radiation exposure. Feedback would be achievable if baseline data were available. It could be another indirect effort to medical radiation reduction.

There are some limitations in this study. First, the retrospective nature of this study could induce some biases. For this reason, we did not have enough data for patients' body habitus, which could be an important source for radiation dose. However, we collected a large number (more than 3,000) of patient CT radiation dose data in multiple hospitals in two time points. Although we included 11 representative protocols in three body parts, other CT scanning protocols and CT examinations of other body parts were not evaluated. The evaluation of scanning parameters such as kVp, mAs, pitch and others were not obtained, those were closely associated with dose optimization ([@B5][@B20][@B21]). However, the purpose of this study was to observe changes of radiation dose itself during three years as a cumulative result of complex protocol optimization, rather than detailed changes of scanning parameters. In addition, we assessed CDTI~vol~ which can be considered a collective measurement of effect of those parameters. There was no objective validation of acquired CT images quality, such as a noise level comparison ([@B5]). However, attending radiologists in each hospital validated the image quality at the time of data collection. In addition, the balance between the tolerable image quality and reduced radiation doses were validated by the clinical reading in daily practices in each hospital. This study observed the radiation dose from a single CT examination. However, the cumulative radiation dose of each patient after repeated examinations is one of the emerging concerns in medical radiation exposure. Further study is needed.

In conclusion, this study showed the efforts of radiologists and medical society for reduction of CT radiation exposure during 3 years. However, the amount of decrement varied according to CT protocols, CT machines and different hospitals, including clinical settings. Adjusting protocols according to clinical requests or special circumstances of some patients, while maintaining acceptable image quality, is needed. To balance the level of clinical needs and ALARA principle, radiologists should be familiar with variable factors influencing CT radiation doses, and active collaboration between radiologists and referring physician are needed. In addition, there should be feedback for patient radiation dose levels for CT examinations, followed by efforts to reducing radiation exposures.
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